News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Jim Cramer expressed his positive view on Eli Lilly (NYSE: LLY), calling it a "good company" he intends to hold for years due to its strong business and drugs. However, he stated he doesn't "really care for" Rigetti Computing, Inc (NASDAQ: RGTI), despite its …
Sharemaestro market context Trend signal active 52 weeks +66.6% · Next-week setup positive 58.3%Eli Lilly and CDMO Resilience are investing $750 million to expand production of Lilly's KwikPen injectable device, used for its diabetes and obesity medications like Mounjaro and Zepbound. This investment will upgrade Resilience's Ohio facility, creating 400 new jobs and aiming for full KwikPen …
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly's KwikPen® injectable device for diabetes and obesity medicines to meet growing patient demand 400 new high-skilled jobs to be created in the Cincinnati, Ohio region Coincides …
The Royal Mint private wealth consultant Stuart O'Reilly tells Proactive's Stephen Gunnion that gold's core drivers remain firmly in place even after its pullback from record highs, citing geopolitical tensions, shifting global alliances, and sustained central bank buying since Russia's invasion of Ukraine. Central …
Sharemaestro market context Price below Trend Line 52 weeks -11.0% · Next-week setup positive 59.1%Eli Lilly and drug manufacturer Resilience are investing $750 million to expand Resilience's Blue Ash operations in Greater Cincinnati, aiming to significantly boost the production of KwikPens for Eli Lilly's popular diabetes and obesity medications like Mounjaro and Zepbound. This expansion is expected to …
This article provides a technical analysis of Scully Royalty Ltd (SRL), covering its price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. The stock (SRL) has a current price momentum score of 5.70 and is trading between …
O'Reilly Automotive (NASDAQ:ORLY) announced its second-quarter earnings, meeting analyst expectations with an EPS of $0.86 and a 6% increase in comparable-store sales. The company provided fiscal 2026 guidance for EPS between $3.20-$3.30 and revenue between $18.9 billion-$19.2 billion, which aligns with market forecasts. Despite …
O'Reilly Automotive (ORLY) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.78 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …
Sharemaestro market context Price below Trend Line 52 weeks -11.0% · Next-week setup positive 59.1%O'Reilly Automotive (NASDAQ:ORLY) has released its FY 2026 earnings guidance, projecting an EPS of $3.20–$3.30 and revenue between $18.9 billion and $19.2 billion, aligning with analyst expectations. Despite this, the stock experienced a 0.6% decline to $90.63 primarily due to insider selling activity, with …
O'Reilly's (NASDAQ:ORLY) Q2 CY2026: Beats On Revenue Auto parts and accessories retailer O'Reilly Automotive (NASDAQ:ORLY) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 8.1% year on year to $4.89 billion. The company expects the full year's revenue to be …
Sharemaestro market context Price above Trend Line 52 weeks -13.9%O’Reilly Automotive Inc. (NASDAQ:ORLY) reported second-quarter earnings that met analyst expectations, but its shares fell 2.9% after hours due to weaker-than-expected full-year 2026 guidance. While revenue slightly exceeded estimates and comparable store sales rose, the company's projected adjusted EPS and revenue midpoints for the …
O'Reilly Automotive, Inc. (ORLY) reported its Q2 revenue at $4.89 billion, surpassing FactSet's estimate of $4.86 billion. The auto parts retailer also recently lifted its annual profit forecast due to sustained demand for replacement parts and provided full-year 2026 revenue and EPS guidance. The …
O'Reilly Automotive Inc. (ORLY) reported strong second-quarter results, with profits of $715.1 million, or 86 cents per share, surpassing Wall Street's expectations of 85 cents per share. The auto parts retailer also exceeded revenue forecasts, posting $4.89 billion against an expected $4.85 billion. For …
Eli Lilly is set to release its Q2 2026 earnings on August 5th. Morningstar has a fair value estimate of $900.00 for LLY, rating it as moderately overvalued with a High Uncertainty Rating due to variable outcomes for key drug launches. Analysts will be …
O’Reilly Automotive, Inc. announced strong financial results for its second quarter ending June 30, 2026, with a 6.0% increase in comparable store sales and a 10% rise in diluted earnings per share to $0.86. The company reported record revenue of $4.89 billion and is …
Sharemaestro market context Price below Trend Line 52 weeks -11.0% · Next-week setup positive 59.1%LLY remains close to its 52-week high with an active weekly Trend Signal, but lighter participation and cooling Market Dynamics make the setup more balanced than the price chart alone suggests.
The market expects Eli Lilly (LLY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might …
O’Reilly Automotive Inc. is set to report second-quarter earnings, with analysts anticipating sequential improvements despite ongoing speculation about a potential multibillion-dollar acquisition of Genuine Parts Company’s NAPA automotive business. Investors will be looking for management clarity on the acquisition rumors, as well as insights …
This article summarizes analyst opinions on three financial stocks: Independent Bank (IBCP), Ally Financial (ALLY), and Robinhood (HOOD). Independent Bank received a "Hold" rating from D.A. Davidson, while Ally Financial was rated a "Buy" by Truist Financial. Robinhood also received a "Buy" rating from …
Amgen is developing MariTide, a monthly injectable weight loss drug, aiming to compete with Eli Lilly's and Novo Nordisk's established treatments. While MariTide offers convenience with its once-a-month dosing, its phase 2 trial data showed less efficacy compared to rival drugs like Eli Lilly's …
Royal Bank of Canada reduced its stake in O'Reilly Automotive (NASDAQ:ORLY) by 23,434 shares (0.5%), though it still holds 5.13 million shares valued at $473.2 million. Insider selling has also occurred, with 105,730 shares worth $9.8 million sold in the last 90 days. Despite …
Quantinno Capital Management LP has significantly increased its stake in O'Reilly Automotive, Inc. (NASDAQ:ORLY) by nearly 50% in the first quarter, now owning 882,175 shares valued at over $81 million. Other institutional investors like Sivia Capital Partners LLC, NewEdge Advisors LLC, and Sei Investments …
This article provides a technical analysis of Ally Financial Inc (ALLY), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. As of July 28, 2026, Ally Financial's stock price is trading between resistance at $46.79 and support …
Ally Financial has received several national recognitions in 2026 for its digital banking services, workplace culture, and innovation. These accolades include being named Best Overall Online Bank by The Wall Street Journal for the fifth consecutive year, ranking #6 on Forbes' World's Best Banks …
Amundi increased its stake in O'Reilly Automotive, Inc. (NASDAQ:ORLY) by 19.7% in the first quarter, now owning 8.49 million shares valued at $784 million. Other institutional investors like Caldwell Trust Co, Jefferies Financial Group Inc., and Goldman Sachs Group Inc. also modified their holdings. …
In the latest close session, Eli Lilly (LLY) was up +2.09% at $1,222.61. The stock outperformed the S&P 500, which registered a daily gain of 0.21%. On the other hand, the Dow registered a gain of 1.03%, and the technology-centric Nasdaq decreased by 0.22%. …
O’Reilly Automotive, Inc. will release its second-quarter 2026 financial results on Wednesday, July 29, 2026, after 3:30 p.m. Central Time, accessible on their website. A conference call for investors and analysts will follow on Thursday, July 30, 2026, at 10:00 a.m. Central Time, with …
This article provides a comprehensive stock analysis of Scully Royalty Ltd (SRL) by TradingKey. It highlights the company's relatively healthy fundamentals, significant growth potential, and fair valuation within the Metals & Mining industry. The analysis covers the company's financial health, valuation, earnings forecast, price …
This article provides a detailed balance sheet for Rallybio Corp (RLYB), offering quarterly and annual financial data spanning several years. It includes key financial metrics such as cash and investments, total assets, liabilities, and shareholders' equity, along with year-over-year changes. The report also features …
Search by ticker symbol or company name and select a result to open its chart.